Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs (Q35024535)

5 August 2017

1 reference

title

Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs (English)

1 reference

5 August 2017

1

Galila Agam

1 reference

5 August 2017

Alon Shamir

2

1 reference

5 August 2017

Galit Shaltiel

series ordinal

3

1 reference

5 August 2017

Miriam L Greenberg

series ordinal

4

1 reference

5 August 2017

publication date

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

4 Suppl 1

1 reference

5 August 2017

page(s)

15-20

1 reference

Inositol phosphates and cell signalling

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Expression of the Saccharomyces cerevisiae inositol-1-phosphate synthase (INO1) gene is regulated by factors that affect phospholipid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

The yeast inositol monophosphatase is a lithium- and sodium-sensitive enzyme encoded by a non-essential gene pair

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

A novel human myo-inositol monophosphatase gene, IMP.18p, maps to a susceptibility region for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

An approach to investigating linkage for bipolar disorder using large Costa Rican pedigrees

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Genomic structure and chromosomal localization of a human myo-inositol monophosphatase gene (IMPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Structure and mechanism of inositol monophosphatase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Lithium and brain signal transduction systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Mutant enrichment of Schizosaccharomyces pombe by inositol-less death

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Anti-bipolar therapy: mechanism of action of lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Distribution and properties of CDP-diglyceride:inositol transferase from brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Inositol monophosphatase activity in brain and lymphocyte-derived cell lines of bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Incorporation of inositol into the phosphoinositides of lymphoblastoid cell lines established from bipolar manic-depressive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Effect of bipolar disorder on lymphocyte inositol monophosphatase mRNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Reduced inositol content in lymphocyte-derived cell lines from bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Effects of myo-inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

Immunohistochemical staining and enzyme activity measurements show myo-inositol-1-phosphate synthase to be localized in the vasculature of brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

7 January 2021

Long-term lithium treatment selectively reduces receptor-coupled inositol phospholipid hydrolysis in rat brain

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

7 January 2021

Subacute and chronic in vivo lithium treatment inhibits agonist- and sodium fluoride-stimulated inositol phosphate production in rat cortex

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

7 January 2021

Selection of spontaneous mutants by inositol starvation in yeast

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

7 January 2021

Epi-inositol is biochemically active in reversing lithium effects on cytidine monophosphorylphosphatidate (CMP-PA). Short communication

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

7 January 2021

Scyllo-inositol in post-mortem brain of bipolar, unipolar and schizophrenic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

7 January 2021

Effects of lithium on platelet membrane phosphoinositides in bipolar disorder patients: a pilot study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.4.S1.2.X

7 January 2021

10.1034/J.1399-5618.4.S1.2.X

Identifiers

DOI

1 reference

5 August 2017

1 reference